188 related articles for article (PubMed ID: 25488473)
1. Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
McColgan P; Viegas S; Gandhi S; Bull K; Tudor R; Sheikh F; Pinney J; Fontana M; Rowczenio D; Gillmore JD; Gilbertson JA; Whelan CJ; Shah S; Jaunmuktane Z; Holton JL; Schott JM; Werring DJ; Hawkins PN; Reilly MM
J Neurol; 2015 Jan; 262(1):228-34. PubMed ID: 25488473
[TBL] [Abstract][Full Text] [Related]
2. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P
World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593
[TBL] [Abstract][Full Text] [Related]
3. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
[TBL] [Abstract][Full Text] [Related]
4. A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.
Nakagawa K; Sheikh SI; Snuderl M; Frosch MP; Greenberg SM
J Neurol Sci; 2008 Sep; 272(1-2):186-90. PubMed ID: 18579156
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis.
Brett M; Persey MR; Reilly MM; Revesz T; Booth DR; Booth SE; Hawkins PN; Pepys MB; Morgan-Hughes JA
Brain; 1999 Feb; 122 ( Pt 2)():183-90. PubMed ID: 10071047
[TBL] [Abstract][Full Text] [Related]
6. Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation.
Kleefeld F; Knebel F; Eurich D; Schatka I; Blüthner E; Schönfeld S; Amthauer H; Hahn K
J Neuromuscul Dis; 2020; 7(4):515-519. PubMed ID: 32741838
[TBL] [Abstract][Full Text] [Related]
7. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
Blevins G; Macaulay R; Harder S; Fladeland D; Yamashita T; Yazaki M; Hamidi Asl K; Benson MD; Donat JR
Neurology; 2003 May; 60(10):1625-30. PubMed ID: 12771253
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis].
Ikeda SI
Brain Nerve; 2013 Jul; 65(7):831-42. PubMed ID: 23832986
[TBL] [Abstract][Full Text] [Related]
9. Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.
Qin Q; Wei C; Piao Y; Lian F; Wu H; Zhou A; Wang F; Zuo X; Han Y; Lyu J; Guo D; Jia J
Neurologist; 2021 Sep; 26(5):189-195. PubMed ID: 34491937
[TBL] [Abstract][Full Text] [Related]
10. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.
Herrick MK; DeBruyne K; Horoupian DS; Skare J; Vanefsky MA; Ong T
Neurology; 1996 Oct; 47(4):988-92. PubMed ID: 8857732
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
Carr AS; Pelayo-Negro AL; Jaunmuktane Z; Scalco RS; Hutt D; Evans MR; Heally E; Brandner S; Holton J; Blake J; Whelan CJ; Wechalekar AD; Gillmore JD; Hawkins PN; Reilly MM
Neuromuscul Disord; 2015 Jun; 25(6):511-5. PubMed ID: 25819286
[TBL] [Abstract][Full Text] [Related]
12. CNS Involvement in Hereditary Transthyretin Amyloidosis.
Sousa L; Coelho T; Taipa R
Neurology; 2021 Dec; 97(24):1111-1119. PubMed ID: 34663645
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
14. Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.
Jin K; Sato S; Takahashi T; Nakazaki H; Date Y; Nakazato M; Tominaga T; Itoyama Y; Ikeda S
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1463-6. PubMed ID: 15377697
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
Gonçalves P; Martins H; Costelha S; Maia LF; Saraiva MJ
Amyloid; 2016 Dec; 23(4):249-253. PubMed ID: 27884058
[TBL] [Abstract][Full Text] [Related]
16. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
Nakamura M; Yamashita T; Ueda M; Obayashi K; Sato T; Ikeda T; Washimi Y; Hirai T; Kuwahara Y; Yamamoto MT; Uchino M; Ando Y
Neurology; 2005 Oct; 65(7):1051-6. PubMed ID: 16217058
[TBL] [Abstract][Full Text] [Related]
17. The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.
Fan K; Zhu H; Xu H; Mao P; Yuan L; Deng H
J Neurol; 2019 Jan; 266(1):232-241. PubMed ID: 30470998
[TBL] [Abstract][Full Text] [Related]
18. Oculoleptomeningeal Amyloidosis Due to Transthyretin p.Y89H (Y69H) Variant.
Quintanilha GS; Cruz MW; Silva MTT; Chimelli L
J Neuropathol Exp Neurol; 2020 Oct; 79(10):1134-1136. PubMed ID: 32856080
[No Abstract] [Full Text] [Related]
19. Hereditary transthyretin-related amyloidosis.
Finsterer J; Iglseder S; Wanschitz J; Topakian R; Löscher WN; Grisold W
Acta Neurol Scand; 2019 Feb; 139(2):92-105. PubMed ID: 30295933
[TBL] [Abstract][Full Text] [Related]
20. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.
Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K
Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
